Insider Stock Trading History of Invus Public Equities Advisors, Llc


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Invus Public Equities Advisors, Llc since year 2005. The trader's CIK number is 1340096. At the time of this reporting, Invus Public Equities Advisors, Llc is the Director of Lexicon Pharmaceuticals, Inc. . (stock ticker symbol LXRX). See this page for all insider trading activities at Lexicon Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Invus Public Equities Advisors, Llc since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-17 LXRX Lexicon Pharmaceuticals, Inc. Buy 50,000 9.85 492,500
2017-11-15 LXRX Lexicon Pharmaceuticals, Inc. Buy 130,727 10.21 1,334,461
2017-11-14 LXRX Lexicon Pharmaceuticals, Inc. Buy 215,133 9.47 2,037,954
2017-11-13 LXRX Lexicon Pharmaceuticals, Inc. Buy 215,133 9.75 2,097,977
2017-11-10 LXRX Lexicon Pharmaceuticals, Inc. Buy 145,680 9.74 1,418,340
2014-11-26 LXRX Lexicon Pharmaceuticals, Inc. Buy 149,253,731 1.00 149,999,999

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Invus Public Equities Advisors, Llc (Director of Lexicon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.